Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

One week of continuous corticosterone exposure impairs hepatic metabolic flexibility, promotes islet β-cell proliferation, and reduces physical activity in male C57BL/6 J mice.

Burke SJ, Batdorf HM, Huang TY, Jackson JW, Jones KA, Martin TM, Rohli KE, Karlstad MD, Sparer TE, Burk DH, Campagna SR, Noland RC, Soto PL, Collier JJ.

J Steroid Biochem Mol Biol. 2019 Dec;195:105468. doi: 10.1016/j.jsbmb.2019.105468. Epub 2019 Sep 16.

PMID:
31536768
2.

The Human Cytomegalovirus Chemokine vCXCL-1 Modulates Normal Dissemination Kinetics of Murine Cytomegalovirus In Vivo.

Jackson JW, Hancock TJ, LaPrade E, Dogra P, Gann ER, Masi TJ, Panchanathan R, Miller WE, Wilhelm SW, Sparer TE.

MBio. 2019 Jun 25;10(3). pii: e01289-19. doi: 10.1128/mBio.01289-19.

3.

Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of In Vitro Screenings.

Jackson JW, Hancock TJ, Dogra P, Patel R, Arav-Boger R, Williams AD, Kennel SJ, Wall JS, Sparer TE.

mSphere. 2019 Feb 13;4(1). pii: e00586-18. doi: 10.1128/mSphere.00586-18.

4.

Exposure of Candida albicans β (1,3)-glucan is promoted by activation of the Cek1 pathway.

Chen T, Jackson JW, Tams RN, Davis SE, Sparer TE, Reynolds TB.

PLoS Genet. 2019 Jan 31;15(1):e1007892. doi: 10.1371/journal.pgen.1007892. eCollection 2019 Jan.

5.

Candida albicans Cannot Acquire Sufficient Ethanolamine from the Host To Support Virulence in the Absence of De Novo Phosphatidylethanolamine Synthesis.

Davis SE, Tams RN, Solis NV, Wagner AS, Chen T, Jackson JW, Hasim S, Montedonico AE, Dinsmore J, Sparer TE, Filler SG, Reynolds TB.

Infect Immun. 2018 Jul 23;86(8). pii: e00815-17. doi: 10.1128/IAI.00815-17. Print 2018 Aug.

6.

Pancreatic islet inflammation: an emerging role for chemokines.

Collier JJ, Sparer TE, Karlstad MD, Burke SJ.

J Mol Endocrinol. 2017 Jul;59(1):R33-R46. doi: 10.1530/JME-17-0042. Epub 2017 Apr 18. Review.

7.

The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in vivo and in vitro.

Pitt EA, Dogra P, Patel RS, Williams A, Wall JS, Sparer TE.

Antiviral Res. 2016 Nov;135:15-23. doi: 10.1016/j.antiviral.2016.09.012. Epub 2016 Sep 25.

8.

Estimating Time Since Death from Postmortem Human Gut Microbial Communities.

Hauther KA, Cobaugh KL, Jantz LM, Sparer TE, DeBruyn JM.

J Forensic Sci. 2015 Sep;60(5):1234-40. doi: 10.1111/1556-4029.12828. Epub 2015 Jun 21.

PMID:
26096156
9.

Novel heparan sulfate-binding peptides for blocking herpesvirus entry.

Dogra P, Martin EB, Williams A, Richardson RL, Foster JS, Hackenback N, Kennel SJ, Sparer TE, Wall JS.

PLoS One. 2015 May 18;10(5):e0126239. doi: 10.1371/journal.pone.0126239. eCollection 2015.

10.

Novel Human Cytomegalovirus Viral Chemokines, vCXCL-1s, Display Functional Selectivity for Neutrophil Signaling and Function.

Heo J, Dogra P, Masi TJ, Pitt EA, de Kruijf P, Smit MJ, Sparer TE.

J Immunol. 2015 Jul 1;195(1):227-36. doi: 10.4049/jimmunol.1400291. Epub 2015 May 18.

11.

CCL20 is elevated during obesity and differentially regulated by NF-κB subunits in pancreatic β-cells.

Burke SJ, Karlstad MD, Regal KM, Sparer TE, Lu D, Elks CM, Grant RW, Stephens JM, Burk DH, Collier JJ.

Biochim Biophys Acta. 2015 Jun;1849(6):637-52. doi: 10.1016/j.bbagrm.2015.03.007. Epub 2015 Apr 13.

12.

Transcription of the gene encoding TNF-α is increased by IL-1β in rat and human islets and β-cell lines.

Burke SJ, Lu D, Sparer TE, Karlstad MD, Collier JJ.

Mol Immunol. 2014 Nov;62(1):54-62. doi: 10.1016/j.molimm.2014.05.019. Epub 2014 Jun 25.

13.

What we have learned from animal models of HCMV.

Dogra P, Sparer TE.

Methods Mol Biol. 2014;1119:267-88. doi: 10.1007/978-1-62703-788-4_15.

PMID:
24639228
14.

NF-κB and STAT1 control CXCL1 and CXCL2 gene transcription.

Burke SJ, Lu D, Sparer TE, Masi T, Goff MR, Karlstad MD, Collier JJ.

Am J Physiol Endocrinol Metab. 2014 Jan 15;306(2):E131-49. doi: 10.1152/ajpendo.00347.2013. Epub 2013 Nov 26.

15.

Repeated administration of tribromoethanol in C57BL/6NHsd mice.

Hill WA, Tubbs JT, Carter CL, Czarra JA, Newkirk KM, Sparer TE, Rohrbach B, Egger CM.

J Am Assoc Lab Anim Sci. 2013 Mar;52(2):176-9.

16.

Screening for novel constitutively active CXCR2 mutants and their cellular effects.

Park G, Masi T, Choi CK, Kim H, Becker JM, Sparer TE.

Methods Enzymol. 2010;485:481-97. doi: 10.1016/B978-0-12-381296-4.00026-9.

PMID:
21050933
17.

Electrical impedance measurements predict cellular transformation.

Park G, Choi CK, English AE, Sparer TE.

Cell Biol Int. 2009 Mar;33(3):429-33. doi: 10.1016/j.cellbi.2009.01.013. Epub 2009 Jan 27.

PMID:
19356706
18.

Feeling manipulated: cytomegalovirus immune manipulation.

Miller-Kittrell M, Sparer TE.

Virol J. 2009 Jan 9;6:4. doi: 10.1186/1743-422X-6-4.

19.
20.

Polymorphisms within human cytomegalovirus chemokine (UL146/UL147) and cytokine receptor genes (UL144) are not predictive of sequelae in congenitally infected children.

Heo J, Petheram S, Demmler G, Murph JR, Adler SP, Bale J, Sparer TE.

Virology. 2008 Aug 15;378(1):86-96. doi: 10.1016/j.virol.2008.05.002. Epub 2008 Jun 16. Erratum in: Virology. 2009 Jan 5;383(1):168-71.

21.

Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV).

Miller-Kittrell M, Sai J, Penfold M, Richmond A, Sparer TE.

Virology. 2007 Aug 1;364(2):454-65. Epub 2007 Apr 11.

22.

Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination.

Noda S, Aguirre SA, Bitmansour A, Brown JM, Sparer TE, Huang J, Mocarski ES.

Blood. 2006 Jan 1;107(1):30-8. Epub 2005 Jul 26.

23.

Expression of human CXCR2 in murine neutrophils as a model for assessing cytomegalovirus chemokine vCXCL-1 function in vivo.

Sparer TE, Gosling J, Schall TJ, Mocarski ES.

J Interferon Cytokine Res. 2004 Oct;24(10):611-20.

PMID:
15626158
24.

Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation.

Arber C, BitMansour A, Sparer TE, Higgins JP, Mocarski ES, Weissman IL, Shizuru JA, Brown JM.

Blood. 2003 Jul 15;102(2):421-8. Epub 2003 Mar 27.

PMID:
12663447
25.
26.

Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.

Hussell T, Georgiou A, Sparer TE, Matthews S, Pala P, Openshaw PJ.

J Immunol. 1998 Dec 1;161(11):6215-22.

27.

Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

Sparer TE, Matthews S, Hussell T, Rae AJ, Garcia-Barreno B, Melero JA, Openshaw PJ.

J Exp Med. 1998 Jun 1;187(11):1921-6.

28.

Suppression of MHC class I antigen presentation by human adenoviruses.

Sparer TE, Gooding LR.

Curr Top Microbiol Immunol. 1998;232:135-47. Review. No abstract available.

PMID:
9557397
29.

Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.

Sparer TE, Wynn SG, Clark DJ, Kaplan JM, Cardoza LM, Wadsworth SC, Smith AE, Gooding LR.

J Virol. 1997 Mar;71(3):2277-84.

30.

Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung.

Kaplan JM, Armentano D, Sparer TE, Wynn SG, Peterson PA, Wadsworth SC, Couture KK, Pennington SE, St George JA, Gooding LR, Smith AE.

Hum Gene Ther. 1997 Jan 1;8(1):45-56.

PMID:
8989994
31.

The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model.

Sparer TE, Tripp RA, Dillehay DL, Hermiston TW, Wold WS, Gooding LR.

J Virol. 1996 Apr;70(4):2431-9.

Supplemental Content

Loading ...
Support Center